An unusually high volume of out-of-the-money (OTM) put options in Edwards Lifesciences (EW), which makes heart valve replacement products, shows investors are bullish on EW stock over the next three months. Moreover, EW is below analysts' price targets.
EW is up slightly at $90.78 in midday trading today. It has rebounded significantly since bottoming out right after its July 23 Q2 earnings release. EW hit a recent low of $82.63 on July 24.
